로딩 중…
지수 로딩 중…
Fate Therapeutics, Inc.
FATE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.09+6.63%
2026-06-18
Price Chart
Fate Therapeutics, Inc.+72.73%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $244M |
| Revenue | $6M |
| Net Income | $-130M |
| Total Assets | $285M |
| Net Assets | $180M |
| Value | |
| P/B | 1.36x |
| P/S | 38.57x |
| FCF Yield | -44.37% |
| Profitability | |
| ROE | -72.29% |
| ROA | -45.59% |
| Op. Margin | -2207.47% |
| Revenue Growth | -20.26% |
| Financial Health | |
| Debt Ratio | 58.54% |
| Total Debt | $77M |
| FCF | $-108M |
| Cash | $40M |
| Current Ratio | 5.85x |
| Performance | |
| 1Y Return | 72.73% |
| 1M Return | 10.58% |
| From 52W High | -27.43% |
| 1Y MDD | -44.83% |
| Trading | |
| Volume | 3,999,782 shares |
| Trading Value | $8M |
| Per Share | |
| EPS | $-1.15 |
| BPS | $1.74 |